TrialMedical oncology (Northwood, London, England)2018

Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping.

George Papaxoinis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.